ketoconazole has been researched along with Foot Dermatoses in 48 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Foot Dermatoses: Skin diseases of the foot, general or unspecified.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An open, comparative, randomized study was conducted using griseofulvin or itraconazole for the treatment of onychomycosis of the foot." | 9.07 | Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent. ( Arenas, R; Domínguez, L; Fernández, G, 1991) |
| "Ten patients with eumycetoma were treated with oral ketoconazole in the dosage of 400mg/day for 8 to 24 months." | 7.68 | Treatment of eumycetoma with ketoconazole. ( Venugopal, PV; Venugopal, TV, 1993) |
| "We report the case of a 30-year-old Nigerian patient with mycetoma of the foot without bone involvement caused by Fusarium sp." | 7.68 | Mycetoma of the foot due to Fusarium sp. treated with oral ketoconazole. ( Baudraz-Rosselet, F; Boccard, C; Borradori, L; Frenk, E; Ginalsky, JM; Monod, M; Vion, B, 1992) |
| "We have treated 48 cases of onychomycosis (of which 37 were caused by dermatophytes, 10 by yeasts and one by Scopulariopsis brevicaulis) with 200 mg ketoconazole daily." | 7.67 | [Ketoconazole and onychomycosis]. ( Achten, G; André, J; Parent, D; Wiame, L, 1984) |
| "A case of mycetoma of the lower leg (Madura foot) with bone involvement caused by Petriellidium boydii is presented." | 5.27 | [Mycetoma caused by Petriellidium boydii: treatment with ketoconazole]. ( Auböck, J; Fritsch, P; Pichler, E, 1985) |
| "An open, comparative, randomized study was conducted using griseofulvin or itraconazole for the treatment of onychomycosis of the foot." | 5.07 | Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent. ( Arenas, R; Domínguez, L; Fernández, G, 1991) |
| " Though griseofulvin was introduced in the late 1950s and was at the time the only Food and Drug Administration (FDA)-approved drug in the United States for the systemic treatment of onychomycosis, its cure rate seldom exceeds 40%." | 4.82 | The systemic treatment of onychomycosis. ( Wenig, JA, 2004) |
| " Griseofulvin, the only drug approved by the Food and Drug Administration for the systemic treatment of onychomycosis, has a cure rate that seldom exceeds 40%." | 4.79 | The systemic treatment of onychomycosis. ( Wenig, JA, 1995) |
| "An economic analysis of the oral antifungal drugs griseofulvin (GRI), ketoconazole (KET), and terbinafine (TER), currently registered and used in treating onychomycosis of fingernails and toenails, was performed using a model that incorporates elements of both meta-analysis and pharmacoeconomics." | 4.79 | Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspective. ( Arikian, SR; Einarson, TR; Shear, NH, 1994) |
| " We conducted a multinational cost-effectiveness analysis, from a government payer perspective, comparing four primary oral treatment regimens for onychomycosis of the fingernails and toenails: griseofulvin, itraconazole, ketoconazole and terbinafine." | 4.79 | A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group. ( Arikian, SR; Einarson, TR; Kobelt-Nguyen, G; Schubert, F, 1994) |
| "Onychomycosis of the toenails is a condition that responds poorly to griseofulvin." | 3.70 | A questionnaire study on the management of onychomycosis: a Canadian perspective. ( Gupta, AK; Shear, NH, 1998) |
| "Ten patients with eumycetoma were treated with oral ketoconazole in the dosage of 400mg/day for 8 to 24 months." | 3.68 | Treatment of eumycetoma with ketoconazole. ( Venugopal, PV; Venugopal, TV, 1993) |
| "We report the case of a 30-year-old Nigerian patient with mycetoma of the foot without bone involvement caused by Fusarium sp." | 3.68 | Mycetoma of the foot due to Fusarium sp. treated with oral ketoconazole. ( Baudraz-Rosselet, F; Boccard, C; Borradori, L; Frenk, E; Ginalsky, JM; Monod, M; Vion, B, 1992) |
| "We have treated 48 cases of onychomycosis (of which 37 were caused by dermatophytes, 10 by yeasts and one by Scopulariopsis brevicaulis) with 200 mg ketoconazole daily." | 3.67 | [Ketoconazole and onychomycosis]. ( Achten, G; André, J; Parent, D; Wiame, L, 1984) |
| "A case of cryptococcosis in a woman 46 years old, with lesions of the skin and the lung with an evolution of six years who answered satisfactory to a treatment with ketoconazole." | 3.67 | [Cryptococcosis. Apropos of a case]. ( Fernández Bussy, RA; Pecoraro, V; Reeves, G, 1988) |
| "rubrum." | 2.40 | Childhood white superficial onychomycosis caused by Trichophyton rubrum: report of seven cases and review of the literature. ( Lucky, AW; Ploysangam, T, 1997) |
| " In addition, the short treatment times (< 3 months) and intermittent dosing schedules are likely to enhance compliance and reduce the costs of therapy." | 2.40 | Onychomycosis: pathogenesis, diagnosis, and management. ( Elewski, BE, 1998) |
| "The management of onychomycosis has changed considerably in the past few years." | 2.38 | Onychomycosis. Agents of choice. ( Hay, RJ, 1993) |
| "flavus eumycetoma confirmed by isolation, molecular identification and immunohistochemical analysis." | 1.42 | Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry. ( Abbas, MA; Ahmed, SA; Al-Hatmi, AM; de Hoog, GS; Jouvion, G; Kolecka, A; Mahgoub, el S, 2015) |
| "A case of eumycetoma of foot in an 8-year old male child was clinically diagnosed as chronic osteomyelitis and was microbiologically confirmed as eumycetoma." | 1.34 | Eumycetoma pedis due to Exophiala jeanselmei. ( Aggarwal, P; Capoor, MR; Deb, M; Hasan, A; Khanna, G; Nair, D, 2007) |
| "Mycotic mycetoma is a chronic, granulomatous and fistulous tropical disease caused by hyphomycetes of different families." | 1.27 | [Mycotic mycetoma (eumycetoma) caused by Madurella mycetomi]. ( Bauer, R; Mittag, H; Montag, H; Niedecken, HW, 1985) |
| "A case of mycetoma of the lower leg (Madura foot) with bone involvement caused by Petriellidium boydii is presented." | 1.27 | [Mycetoma caused by Petriellidium boydii: treatment with ketoconazole]. ( Auböck, J; Fritsch, P; Pichler, E, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (43.75) | 18.7374 |
| 1990's | 18 (37.50) | 18.2507 |
| 2000's | 5 (10.42) | 29.6817 |
| 2010's | 4 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, F | 1 |
| Yang, P | 1 |
| Choi, JS | 1 |
| Antovski, P | 1 |
| Zhu, Y | 1 |
| Xu, X | 1 |
| Kuo, TH | 1 |
| Lin, LE | 1 |
| Kim, DNH | 1 |
| Huang, PC | 1 |
| Xu, H | 1 |
| Lee, CF | 1 |
| Wang, C | 1 |
| Hsu, CC | 1 |
| Chen, K | 1 |
| Weiss, PS | 1 |
| Tseng, HR | 1 |
| Ahmed, SA | 1 |
| Abbas, MA | 1 |
| Jouvion, G | 1 |
| Al-Hatmi, AM | 1 |
| de Hoog, GS | 1 |
| Kolecka, A | 1 |
| Mahgoub, el S | 1 |
| Dalle, S | 1 |
| Toussaint, H | 1 |
| Thomas, L | 1 |
| Pin, D | 1 |
| Vidémont, E | 1 |
| Derian-Autier, D | 1 |
| Guillot, J | 1 |
| Plouzeau, E | 1 |
| Wenig, JA | 2 |
| Capoor, MR | 1 |
| Khanna, G | 1 |
| Nair, D | 1 |
| Hasan, A | 1 |
| Deb, M | 1 |
| Aggarwal, P | 1 |
| Schmid-Wendtner, MH | 1 |
| Korting, HC | 1 |
| Moore, MK | 3 |
| del Palacio-Hernanz, AD | 1 |
| Lopez-Gomez, S | 1 |
| Parent, D | 1 |
| Achten, G | 1 |
| André, J | 1 |
| Wiame, L | 1 |
| Simpson, A | 1 |
| Singh, SR | 1 |
| Hironaga, M | 1 |
| Mochizuki, T | 1 |
| Watanabe, S | 2 |
| Zaias, N | 2 |
| Drachman, D | 1 |
| Shimozuma, M | 1 |
| Takizawa, K | 1 |
| Einarson, TR | 2 |
| Arikian, SR | 2 |
| Shear, NH | 2 |
| Kobelt-Nguyen, G | 1 |
| Schubert, F | 1 |
| Venugopal, PV | 1 |
| Venugopal, TV | 1 |
| Burke, WA | 1 |
| Hay, RJ | 4 |
| Ploysangam, T | 1 |
| Lucky, AW | 1 |
| Markinson, BC | 1 |
| Monter, SI | 1 |
| Cabrera, G | 1 |
| Gupta, AK | 1 |
| Elewski, BE | 1 |
| Torres-Rodríguez, JM | 1 |
| Madrenys-Brunet, N | 1 |
| Siddat, M | 1 |
| López-Jodra, O | 1 |
| Jimenez, T | 1 |
| Débat-Zoguéreh, D | 1 |
| Badiaga, S | 1 |
| Andrac-Meyer, L | 1 |
| Delmont, J | 1 |
| Brouqui, P | 1 |
| Tarasenko, GN | 1 |
| Patronov, IV | 1 |
| Tarasenko, IuG | 1 |
| Kuz'mina, IuV | 1 |
| Crawford, F | 1 |
| Young, P | 1 |
| Godfrey, C | 1 |
| Bell-Syer, SE | 1 |
| Hart, R | 1 |
| Brunt, E | 1 |
| Russell, I | 1 |
| Baran, R | 1 |
| Baudraz-Rosselet, F | 1 |
| Monod, M | 1 |
| Borradori, L | 1 |
| Ginalsky, JM | 1 |
| Vion, B | 1 |
| Boccard, C | 1 |
| Frenk, E | 1 |
| Alteras, I | 1 |
| Hagler, J | 1 |
| Trattner, A | 1 |
| Morojinski, G | 1 |
| Segal, R | 1 |
| Sandbank, M | 1 |
| Arenas, R | 1 |
| Fernández, G | 1 |
| Domínguez, L | 1 |
| Hettinger, DF | 1 |
| Valinsky, MS | 1 |
| Clayton, YM | 3 |
| Midgely, G | 2 |
| Belukha, UK | 1 |
| Bidrat, MS | 1 |
| Luk'ianova, AS | 1 |
| Leshchenko, VM | 1 |
| Kukoleva, LI | 1 |
| Shirshikova, IuI | 1 |
| Rukavishnikova, VM | 1 |
| Dadiomova, VG | 1 |
| DeLauro, TM | 1 |
| Hodge, W | 1 |
| Török, I | 1 |
| Stehlich, G | 1 |
| Daniel, CR | 1 |
| Lawson, LA | 1 |
| Fernández Bussy, RA | 1 |
| Reeves, G | 1 |
| Pecoraro, V | 1 |
| Nilsen, A | 1 |
| Høvding, G | 1 |
| Howell, SA | 1 |
| Noble, WC | 1 |
| Krempl-Lamprecht, L | 1 |
| Luderschmidt, C | 1 |
| Wehrmann, W | 1 |
| Port, M | 1 |
| Heilesen, AM | 1 |
| Rasmussen, E | 1 |
| Mittag, H | 1 |
| Niedecken, HW | 1 |
| Montag, H | 1 |
| Bauer, R | 1 |
| Auböck, J | 1 |
| Pichler, E | 1 |
| Fritsch, P | 1 |
10 reviews available for ketoconazole and Foot Dermatoses
| Article | Year |
|---|---|
The systemic treatment of onychomycosis.
Topics: Antifungal Agents; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; | 2004 |
Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell-mediated immunity.
Topics: Animals; Antifungal Agents; Fluconazole; Foot Dermatoses; Humans; Immunity, Cellular; Itraconazole; | 2007 |
The systemic treatment of onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itracon | 1995 |
Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspective.
Topics: Antifungal Agents; Canada; Cost-Benefit Analysis; Foot Dermatoses; Griseofulvin; Hand Dermatoses; Hu | 1994 |
A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group.
Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Foot Dermatoses; Griseofulvin | 1994 |
Onychomycosis. Agents of choice.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Candidiasis, Cutaneous; Fluconaz | 1993 |
Childhood white superficial onychomycosis caused by Trichophyton rubrum: report of seven cases and review of the literature.
Topics: Allylamine; Antifungal Agents; Child; Child, Preschool; Ciclopirox; Coloring Agents; Female; Foot De | 1997 |
Traditional approaches to treatment of onychomycosis.
Topics: Administration, Topical; Antifungal Agents; Debridement; Foot Dermatoses; Griseofulvin; Humans; Keto | 1997 |
Onychomycosis: pathogenesis, diagnosis, and management.
Topics: Adult; Antifungal Agents; Child; Diagnosis, Differential; Female; Fluconazole; Foot Dermatoses; Hand | 1998 |
Oral treatments for toenail onychomycosis: a systematic review.
Topics: Administration, Oral; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Sched | 2002 |
4 trials available for ketoconazole and Foot Dermatoses
| Article | Year |
|---|---|
A method for the determination of drug effectiveness in onychomycosis. Trials with ketoconazole and griseofulvin ultramicrosize.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Foot Dermatoses; Gri | 1983 |
[Modern local therapy of foot mycoses in servicemen].
Topics: Administration, Cutaneous; Adult; Aged; Antifungal Agents; Dermatomycoses; Female; Foot Dermatoses; | 2001 |
Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent.
Topics: Administration, Topical; Adult; Antifungal Agents; Drug Therapy, Combination; Emollients; Female; Fo | 1991 |
[Ketoconazole in onychomycosis].
Topics: Adult; Clinical Trials as Topic; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans | 1985 |
34 other studies available for ketoconazole and Foot Dermatoses
| Article | Year |
|---|---|
Cross-Linked Fluorescent Supramolecular Nanoparticles for Intradermal Controlled Release of Antifungal Drug-A Therapeutic Approach for Onychomycosis.
Topics: Animals; Antifungal Agents; Cross-Linking Reagents; Female; Fluorescent Dyes; Foot Dermatoses; Ketoc | 2018 |
Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Chronic Disease; Delayed Diagnosis; Diagnostic | 2015 |
[Acquired pigmented lesion of the foot].
Topics: Adolescent; Antifungal Agents; Dermoscopy; Female; Foot Dermatoses; Humans; Ketoconazole; Mitosporic | 2010 |
First description of onychomycosis caused by Chrysosporium keratinophilum in captive Bennett's wallabies (Macropus rufogriseus rufogriseus).
Topics: Animals; Antifungal Agents; Chrysosporium; Female; Foot Dermatoses; Ketoconazole; Macropodidae; Male | 2011 |
Eumycetoma pedis due to Exophiala jeanselmei.
Topics: Antifungal Agents; Child; Exophiala; Foot Dermatoses; Histocytochemistry; Humans; Ketoconazole; Leg; | 2007 |
Scytalidium hyalinum infection diagnosed in Spain.
Topics: Adult; Africa, Central; Clotrimazole; Dermatomycoses; Foot Dermatoses; Humans; Ketoconazole; Male; M | 1984 |
[Ketoconazole and onychomycosis].
Topics: Adolescent; Adult; Aged; Arthrodermataceae; Candidiasis; Female; Foot Dermatoses; Hand Dermatoses; H | 1984 |
A case of Madura foot.
Topics: Drug Therapy, Combination; Foot Dermatoses; Humans; Ketoconazole; Male; Miconazole; Middle Aged; Myc | 1984 |
Cutaneous phaeohyphomycosis of the sole caused by Exophiala jeanselmei and its susceptibility to amphotericin B, 5-FC and ketoconazole.
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Microbial; Female; Flucytosine; | 1982 |
Superficial hyperkeratotic candidiasis on the palms and soles.
Topics: Candida; Candidiasis, Cutaneous; Foot Dermatoses; Hand Dermatoses; Humans; Ketoconazole; Male; Middl | 1983 |
Treatment of eumycetoma with ketoconazole.
Topics: Acremonium; Adolescent; Adult; Female; Foot Dermatoses; Humans; Ketoconazole; Male; Middle Aged; Mit | 1993 |
Tinea nigra: treatment with topical ketoconazole.
Topics: Administration, Topical; Animals; Dermatomycoses; Exophiala; Female; Foot Dermatoses; Humans; Ketoco | 1993 |
A questionnaire study on the management of onychomycosis: a Canadian perspective.
Topics: Administration, Oral; Antifungal Agents; Canada; Dermatology; Female; Foot Dermatoses; Griseofulvin; | 1998 |
Aspergillus versicolor as cause of onychomycosis: report of 12 cases and susceptibility testing to antifungal drugs.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Female; Foot Dermatoses; Humans; Itraco | 1998 |
[Diagnostic case. Mycetoma].
Topics: Adult; Antifungal Agents; Dermatomycoses; Female; Foot Dermatoses; Humans; Ketoconazole; Mycetoma | 1999 |
[New treatments of onychomycoses].
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; H | 1992 |
Mycetoma of the foot due to Fusarium sp. treated with oral ketoconazole.
Topics: Administration, Oral; Adult; Foot Dermatoses; Fusarium; Humans; Ketoconazole; Male; Mycetoma | 1992 |
[Mycetoma with black granules: first case in a native of Israel].
Topics: Adult; Biopsy; Cytoplasmic Granules; Dose-Response Relationship, Drug; Foot Dermatoses; Humans; Isra | 1992 |
Treatment of onychomycosis with nail avulsion and topical ketoconazole.
Topics: Administration, Topical; Adolescent; Adult; Combined Modality Therapy; Female; Foot Dermatoses; Huma | 1991 |
Itraconazole in the management of chronic dermatophytosis.
Topics: Adult; Aged; Antifungal Agents; Chronic Disease; Dermatomycoses; Drug Administration Schedule; Femal | 1990 |
[A comprehensive assessment of the phagocytic activity of the blood neutrophils in patients with rubromycosis treated with griseofulvin and nizoral].
Topics: Biological Products; Blood Bactericidal Activity; Combined Modality Therapy; Foot Dermatoses; Griseo | 1989 |
[Experience in treating patients with rubrophytosis with nizoral].
Topics: Adolescent; Adult; Aged; Chronic Disease; Drug Evaluation; Female; Foot Dermatoses; Hand Dermatoses; | 1989 |
An evaluation of itraconazole in the management of onychomycosis.
Topics: Adult; Aged; Antifungal Agents; Drug Evaluation; Female; Foot Dermatoses; Hand Dermatoses; Humans; I | 1988 |
Onychomycosis.
Topics: Adult; Candida albicans; Candidiasis, Chronic Mucocutaneous; Foot Dermatoses; Glutaral; Griseofulvin | 1985 |
Dermatophytosis. A review of diagnosis and current therapy.
Topics: Administration, Topical; Antifungal Agents; Dermatomycoses; Foot Dermatoses; Griseofulvin; Humans; K | 1986 |
Long term post-treatment follow-up of onychomycoses treated with ketoconazole.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermato | 1986 |
Tinea unguium.
Topics: Foot Dermatoses; Griseofulvin; Humans; Ketoconazole; Onychomycosis | 1987 |
[Cryptococcosis. Apropos of a case].
Topics: Cryptococcosis; Female; Foot Dermatoses; Humans; Ketoconazole; Middle Aged | 1988 |
Management of combined bacterial and fungal foot infection in coal miners.
Topics: Bacterial Infections; Clotrimazole; Coal Mining; Dermatomycoses; Foot Dermatoses; Humans; Ketoconazo | 1988 |
[Chromomycosis caused by Fonsecaea compacta (Carrion 1940) with secondary phaeohyphomycotic infection caused by Phaeosclera dermatioides (Sigler 1981)].
Topics: Adult; Chromoblastomycosis; Dermatomycoses; Foot Dermatoses; Humans; Ketoconazole; Male; Microscopy, | 1987 |
Podiatric dermatology.
Topics: Foot Dermatoses; Humans; Ketoconazole; Laser Therapy; Occlusive Dressings; Pentoxifylline; Retinoids | 1987 |
[Madura foot].
Topics: Female; Foot Dermatoses; Humans; Ketoconazole; Middle Aged; Mycetoma | 1987 |
[Mycotic mycetoma (eumycetoma) caused by Madurella mycetomi].
Topics: Adult; Amoxicillin; Combined Modality Therapy; Foot Dermatoses; Humans; Ketoconazole; Male; Mitospor | 1985 |
[Mycetoma caused by Petriellidium boydii: treatment with ketoconazole].
Topics: Adult; Amputation, Surgical; Foot Dermatoses; Humans; Ketoconazole; Male; Mycetoma; Pseudallescheria | 1985 |